Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




U.S. FDA OKs Medtronic Stimulator for Back and Leg Pain
Link ID 3054
Title U.S. FDA OKs Medtronic Stimulator for Back and Leg Pain
Url http://www.medscape.com/viewarticle/569845?src=rss
Description Medtronic Inc. said on Wednesday that it had won U.S. regulatory approval for its implantable neurostimulation device to treat chronic back and leg pain. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Feb 8, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Tiotropium Linked to Possible Increased Risk of Stroke
  On the basis of an ongoing safety review, MedWatch reports a possible increased risk of stroke with use of tiotropium. Medscape Medical News
Category:   Articles > Business of Medicine


2. HIV Doctor Files Torture Complaint Against Libya
  A Palestinian doctor, who says he was tortured to confess he deliberately infected hundreds of Libyan children with HIV, has filed a complaint against Libya with a U.N. human rights panel, his lawyer said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine


3. Part 1: The Case of the Emergency Department Physician Who Burned Out: Risk Factors, Impact, and Ear
  In part 1 of the new series on The Impaired Physician, Dr. X shows signs of burnout that put his personal and professional life at risk. Would you turn him in? Medscape Internal Medicine
Category:   Articles > Business of Medicine


4. Online Community Displays the "Intimacy" of Diabetes
  Patients with diabetes and their loved ones form special bonds while sharing stories and experiences at the blog, Six Until Me.
Medscape Med Students
Category:   Articles > Business of Medicine


5. PPIs May Be Cost-Effective in Some Patients Taking Prophylactic Aspirin
  At over-the-counter cost, proton pump inhibitors are cost-effective in average-risk patients taking low-dose aspirin for secondary prevention of coronary heart disease. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS